Treatment & Guidelines
The baseline characteristics of the patients in the TAVI and standard therapy groups were generally well balanced. The exceptions were a lower percentage of patients with COPD and atrial fibrillation in the TAVI group compared to the standard therapy group (41.3% vs 52.5%, p=0.04 and 32.9% vs 48.8%, p=0.04, respectively). The overall patient population was at high risk.1*
The rate of death was significantly lower with TAVI than with standard therapy at 1 year and 5 years1,2
At 1 year:1
At 5 years:2
Content relating to Tavi.today is intented for healthcare professionals. Click OK to confirm you are a healthcare professional and proceed.